openPR Logo
Press release

EURONAV ANNOUNCES Q3 RESULTS

10-24-2007 05:47 PM CET | Logistics & Transport

Press release from: Euronav NV

ANTWERP, 23rd October 2007 – The executive committee of Euronav NV (EURONEXT:
EURN) today reported its provisional financial results for the three months ended 30th September 2007.

The company had a result of USD – 23.3 million (2006: USD 53.8 million) or
USD -0.44 (2006: USD 1.02) per share, for the three months ended 30th September 2007. EBITDA was USD 43.8 million (2006: USD 110.5 million).
Euronav owned VLCCs operated through the Tankers International (TI) Pool earned a time charter equivalent, in average for the quarter, of USD 36,500/day (2006: USD 69,500/day). The time charter earnings of the Suezmax fleet which is fixed on long term time charters, was USD 28,900/day for the third quarter (2006: USD 35,860/day). The result is affected by the revaluation at marked-to-market levels of certain non cash items amounting to USD -14 million.

The Freight market for seaborne transportation of crude oil was lower than expected for a third quarter. This is mostly due to a combination of lower demand for transportation and a greater availability of ships especially in the arabian Gulf. Furthermore, the low freight rates were exacerbated by sharply rising bunker costs.
So far in the fourth quarter, Euronav VLCC fleet operated in the tankers International pool has earned USD 28,000/day and 45% of the available days have been fixed.

Management believes that the long-term outlook for the crude tanker markets is
attractive but remains cautious on the outlook for the rest of the year and the start of 2008.

FOR FULL PRESS RELEASE PLEASE GO TO EURONAV CORPORATE WEBITE:
www.euronav.be

Impress Communications Ltd
DMR House
8-10 Cleave Avenue,
Farnborough, Orpington
Kent BR6 7DR
UNITED KINGDOM

Tel: +44 (0) 1689 860660
Fax: +44 (0) 1689 818285
e-mail: info@impresscommunications.org

: Euronav is one of the world's leading independent tanker companies engaged in the ocean transportation of crude oil and petroleum products. The Company's modern fleet consists of interests in 25 very large crude carriers (VLCC) and ultra large crude carriers (ULCC), of which 10 vessels are chartered in from third parties either directly or jointly with partners. 21 VLCCs and 2 ULCCs are managed in the Tankers International pool of which Euronav is one of the major partners. Euronav owns and also operates 14 Suezmaxes and 2 Aframaxes. Euronav also has now a further 4 Suezmaxes and 2 VLCCs under construction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EURONAV ANNOUNCES Q3 RESULTS here

News-ID: 31207 • Views: 1107

More Releases from Euronav NV

FSO AFRICA UPDATE
Euronav NV (EURONEXT BRUSSELS: EURN) today announces that TI Africa Ltd, the joint venture in which OSG and Euronav NV each has a 50% interest, has received a notice of termination from Maersk Oil Qatar concerning the services contract related to the FSO Africa, a vessel currently under conversion to a Floating Storage and Offloading (FSO) service vessel. The joint venture contests the termination notice and continues to believe that
EURONAV TO RAISE USD 125 MILLION
On 4 September 2009, Euronav NV (‘Euronav’) priced its offering (the ‘Offering’) of USD 125 million fixed rate senior unsecured convertible bonds, due 2015 (the ‘Bonds’). The Bonds will be issued at 100 per cent of their principal amount and will bear interest at a rate of 6.5 per cent per annum, payable semi-annually in arrear. The initial conversion price is EUR 16.28375 (or USD 23.16852 at EUR/USD exchange rate
FIRST SEMESTER RESULTS 2009
ANTWERP, Belgium, 22nd July 2009 – The executive committee of Euronav NV (EURONEXT BRUSSELS: EURN) today reported its preliminary and unaudited financial results for the six months ended 30th June 2009. The company had a net income of USD 27.1 million (first semester 2008: USD 205.2 million) or USD 0.54 (first semester 2008: USD 3.97) per share, for the first semester 2009. EBITDA for the same period was USD 123.6 million
FIRST QUARTER RESULTS 2009 AND NEW FINANCING
The executive committee of Euronav NV (EURONEXT BRUSSELS: EURN) today reported its financial results for the three months ended 31st March 2009. The company had a net income of USD 16.8 million (first quarter 2008: USD 80.7 million) or USD 0.34 (first quarter 2008: USD 1.56) per share, for the first quarter 2009. EBITDA for the same period was USD 79 million (first quarter 2008: USD 154.2 million). The average

All 5 Releases


More Releases for USD

$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com. There is a $3,000,000
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size
Metabolomics Market USD 1.24 Billion by 2020
The global metabolomics market is estimated to reach USD 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2016 to 2020, according to a market research report Metabolomics Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Metabolomics Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/ Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which
Radiopharmaceuticals Market USD 350 Million by 2020
Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report https://www.ihealthcareanalyst.com/report/radiopharmaceuticals-market/ Medicinal radiocompounds or radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity and they can be used as diagnostic and therapeutic agents. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone